Cell Cycle and Division

The Cell Cycle

The Cell Cycle

Cell Division, Kinetics & Molecular Control — Cytological and Genetic Basis

Section 1

1. Structural Overview and Thermodynamics of the Cell Cycle

The cell cycle is an exquisitely regulated, unidirectional, and ordered series of physiological events by which a cell duplicates its genomic material, increases its cellular mass, segregates its organelles, and ultimately divides into two daughter cells. This sequence represents the core mechanism of biological continuity. The eukaryotic cell cycle is divided into two primary physiological phases: Interphase, a highly active period of metabolic growth, protein synthesis, and DNA replication occupying approximately 95% of the total cell cycle duration; and M-Phase (mitosis/meiosis and cytokinesis), the brief but highly dynamic period of nuclear and cytoplasmic division.

G2 Phase: Gap 2 (Proofreading & Mass) S Phase: Synthesis (DNA Replication) M Phase (Mitosis / Cytokinesis) G1 Phase: Gap 1 (Growth & Metabolic) G0 Phase (Quiescent State) Restriction Pt. Cyclin E–CDK2 G2/M Checkpoint Cyclin B–CDK1 (MPF) Exit after mitosis Enter quiescence Mitogenic reactivation

Figure 1.1: The eukaryotic cell cycle. G1 progresses into S phase at the restriction point (driven by Cyclin E–CDK2); S phase completes and hands off to G2; the G2/M checkpoint (Cyclin B–CDK1, i.e. MPF) triggers entry into M phase. Cells can exit the active cycle into the quiescent G0 state either from G1 (reversibly, via loss of mitogens or contact inhibition) or after mitosis; mitogenic stimulation can return a quiescent cell from G0 back into G1.

1.1 Subdivisions of Interphase and Chromosomal Ploidy

Interphase is sequentially subdivided into three distinct phases, each associated with a defined chromosome number (n) and DNA content (C):

  1. G1 Phase (Gap 1): The period of active cellular growth, protein synthesis, and metabolic preparation following the completion of the preceding M-phase and preceding the initiation of DNA replication. During G1, a standard diploid somatic cell has a chromosome number denoted as 2n and a genomic DNA content denoted as 2C.
  2. S Phase (Synthesis): The period during which genomic DNA replication occurs, resulting in the doubling of the cellular DNA content from 2C to 4C. Crucially, although each chromosome is replicated to produce two identical sister chromatids, they remain physically linked at their centromere — so there is no increase in chromosome number; the cell remains functionally diploid (2n).
  3. G2 Phase (Gap 2): The final interval of interphase, extending from the completion of S phase to the initiation of M-phase. The cell uses this period to proofread replicated DNA, synthesise tubulin and other spindle components, and accumulate sufficient mass for division. The genomic state remains at 2n chromosomes with 4C DNA content.
G1 Phase 2n , 2C Unreplicated chromosome S Phase 2n , 2C → 4C Replication in progress G2 Phase 2n , 4C Sister chromatids joined at centromere

Figure 1.2: Ploidy across interphase. The chromosome number (n) stays constant across G1, S, and G2 — it is the DNA content (C) that doubles during S phase, since sister chromatids remain joined at a shared centromere rather than counting as separate chromosomes.

Common exam trap: S phase increases DNA content (2C → 4C), not chromosome number. The chromosome number only doubles transiently at anaphase, once sister chromatids separate and are pulled to opposite poles — and it is immediately halved again by cytokinesis.

1.2 The G0 Phase: Quiescence, Senescence, and Differentiation

Cells that exit the active proliferative cycle can enter a specialized, non-dividing resting state termed the G0 phase. This transition can occur reversibly or irreversibly:

  1. Quiescence (G0 state): A reversible resting state entered by cells in response to nutrient deprivation, absence of growth factors, or high cell density. Quiescent cells remain highly metabolically active, continually executing housekeeping functions and energy production, but do not proliferate. Upon restoration of mitogenic stimulation, these cells re-enter the G1 phase.
  2. Senescence: An irreversible loss of proliferative potential. Senescent cells remain alive and metabolically active but are permanently arrested, typically in a G1-like state, and cannot re-enter the active cell cycle even under optimal growth conditions.
  3. Terminal Differentiation: An irreversible exit from the cell cycle to perform highly specialized physiological functions. Examples include mammalian skeletal muscle fibers and mature neurons, which have permanently lost their proliferative capability.
Section 2

2. Kinetic Analysis of Cell Cycle Phase Durations

To determine the precise duration of the individual cell cycle phases (G1, S, G2, and M), researchers employ kinetic assays utilising radioactive or non-isotopic nucleoside analogues.

2.1 Pulse-Chase Labelling and Autoradiography

The classic technique is the fraction of labelled mitoses method, which relies on a pulse-chase experiment:

  1. Pulse Phase: An asynchronous cell culture is exposed for a short period (typically 15 minutes) to tritium-labelled thymidine ([3H]-thymidine) or the thymidine analogue 5-bromo-2'-deoxyuridine (BrdU). Only cells actively synthesising DNA in S phase incorporate the label into their genomic structure.
  2. Chase Phase: The cells are thoroughly washed and incubated in a "chase" medium containing an excess of unlabeled thymidine, ensuring no further cells incorporate the radioactive or immunogenic label.
  3. Sampling and Detection: At regular intervals post-chase, samples of the cell population are fixed, dried onto microscope slides, and analysed. For [3H]-thymidine, autoradiography is performed; for BrdU, immunofluorescence staining with anti-BrdU antibodies is used. The proportion of mitotic cells that carry the label is then scored and plotted over time.
0 50 100 % Labelled Mitoses 0 5 10 15 20 25 30 G2 length S phase duration T – Total generation time (1st wave to 2nd wave)Time After Labelling (Hours)

Figure 2.1: Fraction of labelled mitoses curve. No labelled mitoses appear until the pulse-labelled S-phase cohort finishes traversing G2 — so the delay before the curve first rises from zero sets the minimum G2 duration. The curve's ascending 50% point marks the average G2 length; the interval between the ascending and descending 50% points gives the S phase duration; and the gap between the first and second ascending 50% points (successive waves) gives the total generation time, T.

2.2 Mathematical Determination of Phase Lengths

By plotting the percentage of labelled mitoses against time elapsed after pulse-labelling, each phase length can be extracted from the curve:

G2 duration approximated by= Time to reach 50% on the ascending limb
S phase duration equals= Δt (50% ascending → 50% descending)
Total generation time, T equals= Δt between successive 50%-ascending points
G1 duration by subtraction= T − (S + G2 + M)
Note: M-phase duration is typically measured independently by scoring the mitotic index (the proportion of cells visibly in mitosis at any instant), or approximated as roughly 1 hour in many mammalian cell lines.
Section 3

3. The Molecular Logic of the Cell Cycle Control Engine

The progression of a cell through the cell cycle is driven by an autonomous biochemical oscillator. The central engines of this regulatory system are heterodimeric complexes consisting of a catalytic subunit and a regulatory subunit.

3.1 Cyclin-Dependent Kinases (CDKs)

CDKs are catalytic, serine/threonine protein kinases of approximately 34–40 kDa. While CDKs are constitutively expressed and maintain constant protein levels throughout the cell cycle, they are completely inactive in their monomeric state. Their activation requires association with a specific cyclin partner and subsequent post-translational modifications. Human cells express approximately 20 different CDKs, with CDK1, CDK2, CDK4, and CDK6 directly regulating cell cycle progression, while CDK7 through CDK11 are primarily involved in regulating transcription.

3.2 Cyclins

Cyclins are regulatory proteins that undergo a strict cycle of rapid transcription, translation, and ubiquitin-mediated proteasomal degradation in each cell cycle. They bind to their cognate CDKs, inducing a conformational change that exposes the CDK catalytic site. Cyclins are classified by the specific cell cycle phase they regulate:

  1. G1 Cyclins (Cyclin D): Synthesised during early G1 in response to extracellular mitogens. They bind to CDK4 and CDK6, initiating the phosphorylation of pocket proteins.
  2. G1/S Cyclins (Cyclin E): Accumulate in late G1. They bind to CDK2, driving the cell past the restriction point and committing it to DNA replication.
  3. S Cyclins (Cyclin A): Accumulate during S phase. They associate with CDK2 and CDK1 to maintain DNA replication and prevent re-replication.
  4. M Cyclins (Cyclin B): Accumulate during G2. They bind to CDK1, forming the Mitosis-Promoting Factor (MPF) that triggers nuclear division.
Cyclin B – CDK1 M-CDK · drives M phase Cyclin A – CDK1 / CDK2 S/G2-CDK · drives S phase, G2/M entry Cyclin E – CDK2 G1/S-CDK · drives restriction point Cyclin D – CDK4 / CDK6 G1-CDK · response to mitogens PROGRESSION THROUGH THE CYCLE Cycle repeats: G1 → S → G2 → M → (new G1)

Figure 3.1: The cyclin-CDK cascade. Successive waves of cyclin synthesis and destruction activate different CDK partners in strict order — Cyclin D–CDK4/6 responds to mitogens in G1, Cyclin E–CDK2 drives the G1/S transition, Cyclin A–CDK1/2 sustains S phase and licenses G2/M entry, and Cyclin B–CDK1 (MPF) triggers mitosis — after which the cycle resets.

3.3 Evolutionary Conservation: Yeast vs. Vertebrates

The fundamental architecture of the cell cycle engine is highly conserved across all eukaryotic taxa, though the number of distinct cyclins and CDKs varies:

OrganismPhase / TransitionCyclin PartnerCDK Catalytic Subunit
S. pombe (fission yeast)Entire cell cycle (unicellular)Cdc13Cdc2 (CDK1)
S. cerevisiae (budding yeast)G1 PhaseCln3Cdc28 (CDK1)
 G1/S TransitionCln1, Cln2Cdc28 (CDK1)
 S PhaseClb5, Clb6Cdc28 (CDK1)
 M PhaseClb1–Clb4Cdc28 (CDK1)
VertebratesG1 PhaseCyclin D (D1, D2, D3)CDK4, CDK6
 G1/S TransitionCyclin ECDK2
 S PhaseCyclin ACDK2, CDK1
 G2/M TransitionCyclin ACDK1
 M PhaseCyclin BCDK1
Section 4

4. Multi-layered Regulation of Cyclin-CDK Activity

To ensure that transitions between cell cycle phases are switch-like and irreversible, the activity of cyclin-CDK complexes is controlled by three distinct regulatory mechanisms.

4.1 Activating and Inhibitory Phosphorylation Events

The enzymatic activity of a formed cyclin-CDK complex is strictly dependent on its phosphorylation state, as exemplified by the regulation of mitotic CDK1 (Cdc2) in fission yeast:

  1. Inhibitory Phosphorylation (Wee1 Kinase): The protein kinase Wee1 phosphorylates a critical tyrosine residue at position 15 (Tyr-15) — and an adjacent threonine at position 14 in vertebrates — within the ATP-binding pocket of CDK1. This phosphorylation structurally blocks ATP binding, rendering the complex inactive even if cyclin B is fully bound.
  2. Activating Phosphorylation (CAK): The CDK-Activating Kinase (CAK) phosphorylates a conserved threonine residue at position 161 (Thr-161) within the T-loop of CDK1. This phosphorylation is a prerequisite for full kinase activity, as it stabilises the active conformation of the catalytic cleft.
  3. Dephosphorylation (Cdc25 Phosphatase): For the complex to be activated, the inhibitory phosphates at Tyr-15 (and Thr-14) must be removed. This is executed by the dual-specificity phosphatase Cdc25. Under normal conditions, activation of Cdc25 triggers a rapid, positive feedback loop that converts the inactive pool of CDK1 into an active state, driving entry into mitosis.
Cyclin B – CDK1 Inactive (unphosphorylated) + Tyr-15 phosphate added Inactive + Thr-161 phosphate added Still inactive (Tyr-15 blocks site) Tyr-15 phosphate removed FULLY ACTIVE (MPF) Wee1 kinase Adds inhibitory phosphate to Tyr-15 CAK Adds activating phosphate to Thr-161 Cdc25 phosphatase Removes the inhibitory Tyr-15 phosphate

Figure 4.1: Three-way phosphorylation control of CDK1. Cyclin binding alone is not sufficient for activity. Wee1 imposes an inhibitory brake at Tyr-15; CAK independently adds an activating phosphate at Thr-161, but the complex remains blocked until Cdc25 removes the Tyr-15 phosphate — the step that finally unleashes full MPF activity and commits the cell to mitosis.

4.2 CDK Inhibitor Proteins (CKIs)

CKIs physically bind to cyclin-CDK complexes and block their kinase activity. In mammals, they are grouped into two distinct gene families based on sequence homology and target specificity:

  1. The CIP/KIP Family (p21, p27, p57): These inhibitors contain a conserved domain that allows them to bind to and inhibit a broad range of CDKs — specifically the heterodimers of Cyclin D–CDK4/6, Cyclin E–CDK2, and Cyclin A–CDK2. They wrap around both the cyclin and CDK subunits, disrupting the ATP binding site.
  2. The INK4 Family (p15, p16, p18, p19): These inhibitors are highly specific for monomeric CDK4 and CDK6. They bind to the CDK subunit, preventing its association with D-type cyclins.

4.3 Ubiquitin-Mediated Proteasomal Degradation

Irreversible transitions are driven by targeted protein destruction, mediated by two major classes of multi-subunit E3 ubiquitin ligases:

  1. The SCF Complex (SKP1–Cullin–F-box): Active from late G1 through early M-phase. It consists of four core subunits — SKP1 (an adaptor protein), Cullin 1 / CUL1 (a structural scaffold), RBX1 (a RING-finger catalytic subunit that recruits the E2 ubiquitin-conjugating enzyme), and a variable F-box protein substrate receptor (e.g. Skp2, Fbxw7) that binds target proteins only after they have been phosphorylated. The SCF complex primarily targets CKIs (like p27) and G1/S cyclins for polyubiquitylation and subsequent degradation by the 26S proteasome.
  2. The Anaphase-Promoting Complex / Cyclosome (APC/C): A large, 15–17 subunit complex active from anaphase through the end of G1. The APC/C does not require pre-phosphorylation of its substrates. Instead, its temporal activity and target specificity are regulated by its association with one of two WD40-repeat coactivator proteins: Cdc20, which activates the APC/C at the metaphase-to-anaphase transition and targets the mitotic spindle inhibitor securin and the M-phase cyclins (Cyclin B) for degradation; and Cdh1, which maintains APC/C activity during late mitosis and G1 and is itself phosphorylated and inactivated by active G1/S-CDKs, allowing cyclins to re-accumulate as the cell prepares for a new cycle.
SCF Complex (Active: late G1 → early M) CUL1 Scaffold SKP1 RBX1 F-box protein (substrate receptor)Recognises phosphorylated substrate (CKIs, G1/S cyclins)Recruits E2 ubiquitin- conjugating enzymeAPC/C Complex (Active: anaphase → end of G1) APC/C Core Cdc20 Cdh1(Metaphase → Anaphase) (Anaphase → G1) Destroys securin & M-cyclins (Cyclin B)Destroys remaining M-cyclins in late M / G1

Figure 4.2: The two major cell cycle E3 ubiquitin ligases. SCF recognises pre-phosphorylated substrates via its interchangeable F-box receptor and is active from late G1 to early M; APC/C needs no priming phosphorylation and switches targets by swapping coactivators — Cdc20 at the metaphase/anaphase transition, then Cdh1 through late mitosis and G1.

Section 5

5. Genetic Analysis of Fission Yeast Cell Cycle Mutants

The genetic dissection of the cell cycle was largely accomplished through isolation of temperature-sensitive (ts) mutants in the fission yeast Schizosaccharomyces pombe. At the permissive temperature (e.g. 25°C), the mutated proteins fold and function normally; at the restrictive temperature (e.g. 37°C), they denature and exhibit a complete loss of function.

5.1 Wee1 and Cdc25 Antagonism

Wee1 and Cdc25 exert opposing, antagonistic regulatory control over the entry of cells into mitosis:

  1. Wild-Type Cells: Grow to a specific critical size during G2 before entering mitosis. At this point, the inhibitory phosphorylation of CDK1 by Wee1 is overridden by the activating dephosphorylation by Cdc25, resulting in division at a normal, uniform cell length.
  2. Loss-of-function wee1 mutants: In the absence of Wee1 kinase activity, CDK1 cannot be phosphorylated at Tyr-15, so the inhibitory brake is absent. Cells enter mitosis prematurely, immediately upon completing S phase, without undergoing the necessary G2 growth — resulting in the division of exceptionally small, short cells, termed wee mutants.
  3. Loss-of-function cdc25 mutants: In the absence of Cdc25 phosphatase activity, the inhibitory Tyr-15 phosphate deposited by Wee1 cannot be removed. CDK1 remains permanently inactive, and the cells are arrested at the G2/M boundary. However, metabolic growth continues — the cells cannot divide, resulting in the formation of highly elongated, filamentous cells.
Wild-Type Normal G2 growth → division at critical size G2 M Normal-sized daughter cellswee1 Mutant No inhibitory brake → premature division G2 M Small “wee” cells (premature division)cdc25 Mutant Persistent inhibition → permanent arrest, growth continues G2 — Arrested (Tyr-15 phosphate never removed) Elongated filamentous cell — no division

Figure 5.1: Wee1/Cdc25 antagonism and mutant phenotypes. Wild-type cells balance Wee1's inhibitory brake against Cdc25's activating dephosphorylation, dividing at a uniform critical size. Losing Wee1 removes the brake entirely, so cells divide as soon as they finish S phase — before reaching normal size — producing small "wee" cells. Losing Cdc25 leaves the Wee1-imposed brake permanently in place: CDK1 never activates, the cell cannot enter mitosis, and continued growth without division produces long, filamentous cells.

Key concept — opposite mutant phenotypes reveal opposite functions: because wee1 and cdc25 mutants produce essentially mirror-image phenotypes (too-early vs. never division) from disrupting two enzymes that act on the very same residue (Tyr-15), this classic genetic result was central evidence that Wee1 and Cdc25 act as antagonistic regulators of a single molecular switch, rather than as independent pathways.
Section 6

6. Control of DNA Replication Licensing in S Phase

To maintain genomic stability, eukaryotic cells must replicate their entire genome exactly once per cell cycle. This is achieved by separating the physical assembly of replication machinery from its activation.

6.1 The Pre-Replication Complex (Pre-RC)

The assembly of the pre-replication complex (pre-RC) is restricted to early G1 phase, a period characterised by low CDK activity:

  1. ORC Binding: The heterohexameric Origin Recognition Complex (ORC1–6) binds constitutively to chromosomal replication origins.
  2. Licensing Factor Recruitment: During early G1, the loading factors Cdc6 and Cdt1 bind to the ORC.
  3. MCM Loading: Cdc6 and Cdt1 use ATP hydrolysis to load the MCM2–7 complex — a ring-shaped, inactive hexameric DNA helicase — onto the double-stranded DNA surrounding the origin. Once loaded, the origin is considered "licensed".
ORC (1–6) Cdc6 Cdt1 ATP hydrolysis loads MCM MCM (2–7) Inactive helicase ring ORIGIN LICENSED

Figure 6.1: Pre-RC assembly (licensing). ORC marks the origin constitutively; in early G1, Cdc6 and Cdt1 dock onto ORC and together use ATP hydrolysis to load the inactive MCM2–7 helicase ring around the DNA duplex, licensing the origin for one round of replication.

6.2 Prevention of Re-Replication

Upon transition into S phase, S-CDK and DDK (Dbf4-Dependent Kinase) activate the loaded MCM helicase, converting the pre-RC into an active replication fork. Simultaneously, S-CDK initiates a series of redundant inhibitory pathways to prevent any new pre-RC assembly until the next G1 phase:

  1. Cdc6 Degradation: S-CDK phosphorylates Cdc6, targeting it for polyubiquitylation by the SCF complex and subsequent proteasomal degradation.
  2. Cdt1 Inhibition by Geminin: The protein geminin accumulates during S, G2, and early M-phases. Geminin physically binds to and sequesters free Cdt1, preventing it from loading further MCM helicases. Geminin is only destroyed in late mitosis when the APC/C–Cdc20 complex is activated.
S-CDK / DDK Phosphorylation MCM Activated (CMG) Licensing Inhibited Replication fork advances • Cdc6 phosphorylated & degraded (SCF) • Cdt1 bound & blocked by Geminin Fork Advances No Re-replication

Figure 6.2: The licensing block during S phase. The same S-CDK/DDK activity that fires existing origins also dismantles the machinery needed to license new ones — via redundant Cdc6 degradation and Geminin-mediated Cdt1 sequestration — ensuring each origin fires exactly once per cycle.

Why redundancy matters: S-CDK blocks re-licensing through two independent, parallel mechanisms (destroying Cdc6 and sequestering Cdt1). This redundancy is a recurring exam theme — losing just one of the two safeguards is not sufficient to cause re-replication, underscoring how critical once-per-cycle replication is to genomic stability.
Section 7

7. Rao and Johnson's Cell Fusion Experiments

In 1970, Potu Rao and Robert Johnson conducted classic cell fusion experiments that provided the first direct physiological evidence for the existence of diffusible, stage-specific cytoplasmic regulators of the cell cycle. They used Sendai virus to fuse mammalian cells at different stages of the cell cycle, generating multinucleate heterokaryons.

G1 + S Fusion G1 + S G1 nucleus abruptly initiates S-phase (diffusible S-CDK enters G1) G2 + S Fusion G2 + S G2 nucleus does NOT replicate DNA (origins already relicensed-blocked) G1 + G2 Fusion G1 + G2 Each nucleus stays on its own normal schedule (G2 entry into mitosis is delayed)

Figure 7.1: Rao & Johnson heterokaryon outcomes. Fusing a G1 nucleus with S-phase cytoplasm forces the G1 nucleus into premature replication; fusing a G2 nucleus with S-phase cytoplasm does not induce re-replication, since the G2 origins are already licensing-blocked; and fusing G1 with G2 leaves each nucleus running on its own independent schedule.

7.1 Interpretation of Results

  1. G1 + S Fusion: The G1 nucleus contains licensed replication origins. The diffusible S-phase promoting factors (now known to be active S-CDKs) present in the S-phase cell's cytoplasm immediately translocate into the G1 nucleus, triggering DNA replication.
  2. G2 + S Fusion: The G2 nucleus has already replicated its DNA and disassembled its pre-RCs. Because S-CDK activity remains high, Cdt1 is inhibited and Cdc6 is absent, preventing the G2 origins from being re-licensed. This proved the existence of an irreversible block to re-replication.
  3. G1 + G2 Fusion: The G2 nucleus cannot induce S-phase in the G1 nucleus, and the G1 nucleus cannot induce DNA replication in the G2 nucleus. This demonstrated that the signals inducing replication do not persist into G2.
Section 8

8. The Chromosome Segregation Engine: Cohesin and Cleavage

During S phase, newly replicated sister chromatids are physically held together along their entire length. This cohesion is mediated by a multi-subunit protein ring.

8.1 Structure of the Cohesin Complex

Cohesin is a member of the SMC (Structural Maintenance of Chromosomes) family of proteins. It forms a tripartite, closed ring-like structure consisting of SMC1 and SMC3 — long, coiled-coil proteins that fold back on themselves, associating at one end via their hinge domains and containing ATP-binding head domains at the opposite end — bridged by the kleisin proteins SCC1 (Rad21) and SCC3 (SA1/2), which physically connect the ATPase heads of SMC1 and SMC3 to complete the ring.

Hinge Region SMC1 SMC3 Coiled-coil stalks Head Head SCC1 (Rad21) SCC3 (SA1/2) — kleisin bridge Closed tripartite ring encircles sister chromatids

Figure 8.1: The cohesin ring. SMC1 and SMC3 fold into long coiled-coil arms joined at a flexible hinge; their ATPase head domains at the opposite end are bridged by the SCC1/SCC3 kleisin subunits, closing the structure into a ring that topologically encircles the two sister chromatids.

8.2 The Metaphase-to-Anaphase Transition Pathway

Sister chromatid separation is regulated by a proteolytically driven cascade:

  1. Securin–Separase Complex: Throughout interphase and early mitosis, the highly active cysteine protease separase is kept inactive by its binding to the inhibitory chaperone securin.
  2. APC/C–Cdc20 Activation: Once all chromosomes are aligned at the metaphase plate and have achieved correct bipolar attachment to the spindle, the Anaphase-Promoting Complex is activated by its coactivator Cdc20.
  3. Securin Ubiquitylation: APC/C–Cdc20 acts as an E3 ubiquitin ligase, adding polyubiquitin chains to securin, targeting it for rapid degradation by the 26S proteasome.
  4. Separase Release: The destruction of securin releases free, active separase.
  5. Cohesin Cleavage: Active separase cleaves the SCC1 (Rad21) subunit of the cohesin complex. This breaks the protein ring holding the sister chromatids together, allowing the mitotic spindle to pull them toward opposite poles.
Securin bound to Separase Separase INACTIVE (Metaphase) Securin ubiquitylated 26S proteasome Securin degraded Separase released — ACTIVE Cleaves SCC1 (Rad21) Cohesin ring opens — chromatids separate APC/C–Cdc20 activated Triggered once SAC is satisfied

Figure 8.2: The metaphase–anaphase proteolytic cascade. APC/C–Cdc20 activation triggers securin's destruction, freeing separase to cleave the SCC1 kleisin subunit and physically open the cohesin ring — the single molecular event that permits sister chromatids to separate.

Section 9

9. The Spindle Assembly Checkpoint (SAC)

The Spindle Assembly Checkpoint (SAC) is a sensor system that monitors the attachment of spindle microtubules to kinetochores. It prevents the metaphase-to-anaphase transition until every single chromosome is aligned at the metaphase plate and is under bipolar tension.

9.1 Kinetochore Attachment Configurations

  1. Amphitelic (Bipolar) Attachment: The correct configuration. One sister kinetochore is attached to microtubules from one spindle pole, and the other is attached to microtubules from the opposite pole. This generates physical tension across the centromere.
  2. Monotelic Attachment: Only one sister kinetochore is attached to a spindle pole; the other is completely unattached.
  3. Syntelic Attachment: Both sister kinetochores are attached to microtubules originating from the same spindle pole.
  4. Merotelic Attachment: One kinetochore is attached to microtubules originating from both spindle poles simultaneously. This is a critical defect because it does not generate normal checkpoint signals, often leading to aneuploidy.
Amphitelic Opposite poles (correct, under tension)Monotelic One kinetochore unattachedSyntelic Both to same pole (no tension)Merotelic One kinetochore → both poles at once

Figure 9.1: Kinetochore–spindle attachment geometries. Only amphitelic attachment generates the bipolar tension the SAC reads as "correct." Monotelic, syntelic, and merotelic attachments all fail to generate that tension signal (merotelic especially so, since it mimics a partially-attached, tension-bearing state), risking mis-segregation and aneuploidy if not corrected before anaphase.

9.2 Molecular Mechanism of SAC Signalling

The SAC operates via a signal amplification cascade at unattached kinetochores:

  1. Unattached Kinetochore Scaffold: An unattached kinetochore recruits the SAC proteins Mad1, Mad2, Mad3 (BubR1), Bub1, and Bub3.
  2. Mad2 Conformational Change: Mad2 exists in two distinct stable conformations: open (o-Mad2) and closed (c-Mad2). Kinetochore-bound Mad1 forms a stable complex with c-Mad2, which acts as a template to convert soluble, inactive o-Mad2 into active c-Mad2.
  3. MCC Assembly: Active c-Mad2 rapidly binds to Mad3 (BubR1), Bub3, and Cdc20, forming the soluble Mitotic Checkpoint Complex (MCC).
  4. APC/C Inhibition: The MCC acts as a potent, pseudo-substrate inhibitor of the APC/C. By sequestering Cdc20 within the MCC, the APC/C remains inactive, preventing the degradation of securin and cyclin B, thus halting the cell in metaphase.
  5. Aurora B Tension Sensor: Correct bipolar attachment generates mechanical tension across the centromere, pulling the kinetochores away from the centromere-localised Aurora B kinase. This stops the phosphorylation of microtubule-binding components, stabilising the attachment. Once all kinetochores are attached and under tension, MCC production ceases, Cdc20 is released, and APC/C–Cdc20 initiates anaphase.
SAC ON — Unattached Kinetochore SAC OFF — Bipolar Tension Unattached kinetochore Kinetochores under bipolar tension Recruits Mad1–Mad2 Aurora B pulled from kinetochore o-Mad2 → c-Mad2 conversion MCC production ceases MCC assembles (Mad2–Mad3–Bub3–Cdc20) MCC disassembled, Cdc20 released Inhibits APC/C–Cdc20 APC/C–Cdc20 active ARREST (Metaphase) ANAPHASE ENTRY

Figure 9.2: SAC signal amplification versus satisfaction. A single unattached kinetochore is enough to generate MCC and hold the whole cell in metaphase, regardless of how many other kinetochores are correctly attached. Only once every kinetochore reaches bipolar tension does Aurora B release its grip, MCC production stop, and Cdc20 become free to activate the APC/C.

Common exam trap: the SAC is satisfied by attachment, but the MCC is disassembled by tension across the centromere (sensed via Aurora B). A syntelic attachment is technically "attached" on both sides yet generates no tension — so it is still detected and corrected, unlike what a naive "attached = safe" reading would suggest.
Section 10

10. The DNA Damage Response (DDR) Signalling Pathway

Eukaryotic cells possess a multi-layered signal transduction network, the DNA Damage Response (DDR), that detects lesions in the genomic structure, arrests cell cycle progression to allow repair, and initiates programmed cell death (apoptosis) if the damage is irreparable. The DDR is mediated by two parallel kinase cascades, initiated by the apical PI3K-like protein kinases ATM and ATR.

Double-Strand Breaks (DSBs) Single-Strand Breaks / Stalled Forks MRN Complex RPA – ATRIP ATM Kinase ATR Kinase Chk2 Kinase Chk1 Kinase p53 Cdc25 Cdc25 p53 Transcription Arrest Arrest Transcription

Figure 10.1: The ATM and ATR checkpoint cascades. Double-strand breaks are sensed by the MRN complex and signal through ATM–Chk2; single-strand damage and stalled forks are sensed by RPA–ATRIP and signal through ATR–Chk1. Both cascades converge on the same two effectors, p53 (transcriptional response) and Cdc25 (direct cell cycle arrest), giving the cell a fast, transcription-independent brake alongside a slower, transcription-dependent one.

10.1 The ATM Pathway (Double-Strand Breaks)

  1. Detection: Double-strand breaks (DSBs) are recognized by the heterotrimeric MRN complex (Mre11, Rad50, and Nbs1).
  2. Activation: The MRN complex recruits and activates ATM (Ataxia Telangiectasia Mutated) kinase at the site of the break.
  3. Transduction: Active ATM phosphorylates and activates the downstream checkpoint kinase Chk2.
  4. Effector action: Chk2 phosphorylates Cdc25 dual-specificity phosphatases — this creates a binding site for 14-3-3 proteins, which sequester Cdc25 in the cytoplasm (or target it for degradation), maintaining inhibitory Tyr-15 phosphorylation on CDKs and causing arrest. In parallel, ATM and Chk2 phosphorylate p53 at specific serine residues (e.g. Ser-15, Ser-20), preventing its interaction with its negative regulator, Mdm2.

10.2 The ATR Pathway (Single-Strand Breaks / Replication Stress)

  1. Detection: Single-strand DNA breaks (SSBs) or stalled replication forks are coated by the single-stranded DNA-binding protein RPA (Replication Protein A).
  2. Activation: RPA recruits the adaptor protein ATRIP (ATR-Interacting Protein), which activates ATR (Ataxia Telangiectasia and Rad3 related) kinase.
  3. Transduction: ATR phosphorylates and activates the downstream checkpoint kinase Chk1.
  4. Effector action: Active Chk1 phosphorylates and inactivates Cdc25, leading to rapid cell cycle arrest.
Section 11

11. Molecular Pathology of pRb and p53 Tumour Suppressors

The RB1 and TP53 genes code for the two most critical tumour suppressor proteins in mammalian biology. Their loss or inactivation is a near-universal hallmark of human malignancy.

11.1 The Retinoblastoma (pRb)–E2F Regulatory Loop

The retinoblastoma protein pRb operates as the master gatekeeper of the G1/S phase transition:

  1. Hypophosphorylated State (Active Brake): In early G1, pRb is unphosphorylated or hypophosphorylated. It physically binds the transactivation domain of the E2F transcription factor family, keeping it inactive, and recruits histone deacetylases (HDACs) to E2F-responsive promoters, silencing genes required for S phase entry.
  2. Phosphorylation Cascade: In response to extracellular mitogens, G1-CDK (Cyclin D–CDK4/6) is activated and phosphorylates pRb. This initial phosphorylation weakens the pRb–E2F interaction, allowing transcription of some genes, including Cyclin E.
  3. Hyperphosphorylation (Release): The newly synthesised Cyclin E associates with CDK2 (forming G1/S-CDK), which hyperphosphorylates pRb at multiple serine/threonine sites. Hyperphosphorylated pRb undergoes a conformational change that forces its dissociation from E2F.
  4. S-Phase Commitment: Free E2F homodimerises with its partner protein DP and transactivates genes required for DNA replication (DNA Polymerase α, Thymidine Kinase, PCNA, Cyclin A), committing the cell to division.
Early G1 — pRb Active Late G1 — pRb Inactivated pRb bound to E2F HDAC recruited; E2F genes silenced ARREST Cyclin D – CDK4/6 Phosphorylates pRb Cyclin E – CDK2 Hyperphosphorylates pRb pRb Dissociates from E2F E2F – DP Heterodimer Transactivation of S-phase genes (Cyclin A, PCNA...)

Figure 11.1: The pRb–E2F switch. As long as pRb is unphosphorylated it silences E2F target genes and holds the cell in G1. Sequential phosphorylation — first by Cyclin D–CDK4/6, then hyperphosphorylation by Cyclin E–CDK2 — forces pRb off E2F, freeing E2F–DP to transactivate the S-phase transcriptional programme.

11.2 The p53 Transactivation and Apoptosis Cascade

The transcription factor p53 (encoded by TP53 on chromosome 17p13.1) is kept at low levels in healthy cells by Mdm2, an E3 ubiquitin ligase that binds the N-terminus of p53 and targets it for polyubiquitylation and proteasomal degradation. Under DNA damage, ATM/ATR and Chk1/Chk2 phosphorylate both p53 and Mdm2, disrupting their interaction and stabilising p53, which then forms homotetramers and transactivates downstream targets.

DNA Damage / Cellular Stress ATM / Chk2 Phosphorylation p53 Stabilised Mdm2 Inactivated p53 Homotetramers Transactivates p21 Inhibits G1/S-CDK G1 ARREST Transactivates Puma/Noxa Inhibits Bcl-2 / Bcl-XL / Bcl-w Bax / Bak Oligomerise MOMP Cytochrome c Released

Figure 11.2: The p53 stress-response cascade. ATM/Chk2 signalling both stabilises p53 directly and disables its own repressor, Mdm2 — a coherent feed-forward design. Once tetramerised, p53 branches into a cell-cycle-arrest programme (via p21) and, if damage persists, an apoptotic programme (via Puma/Noxa) that culminates in mitochondrial outer membrane permeabilisation and caspase activation.

Why two parallel inputs into p53 stabilisation? Phosphorylating p53 directly makes it a poorer Mdm2 substrate, while phosphorylating Mdm2 independently impairs Mdm2's ligase activity — disabling the "off switch" from two directions simultaneously ensures a fast, robust, switch-like stabilisation of p53 rather than a slow, leaky one.
Section 12

12. Replicative Senescence, Telomeres, and Telomerase

Normal mammalian somatic cells exhibit a finite replicative capacity in vitro, a limit known as the Hayflick limit. Once this limit is reached, cells enter a state of permanent growth arrest termed replicative senescence.

12.1 The End-Replication Problem

Somatic cells cannot replicate the extreme 3′-ends of linear chromosomes. This is because DNA polymerase requires a pre-existing RNA primer to initiate synthesis, leaving a gap at the 3′-end of the lagging strand after the RNA primer is removed. Consequently, telomeric DNA shortens with each round of replication.

12.2 Telomere Structure and the Shelterin Complex

Telomeres consist of tandem hexanucleotide repeats (5′-TTAGGG-3′ in vertebrates) ending in a single-stranded 3′-overhang. This overhang folds back to form a protective T-loop, stabilised by a six-protein complex called shelterin (the telosome).

T-Loop Structure Chromosome Double-stranded TTAGGG repeats 3′ Overhang invades the duplex (D-loop)Shelterin Complex TRF1 / TRF2 (Binds ds-TTAGGG) TIN2 TPP1 – POT1 (Binds ss-TTAGGG) RAP1 (Protective cap)

Figure 12.1: T-loop and shelterin. The single-stranded 3′ overhang tucks back into the double-stranded telomeric repeat array to form a protective T-loop; the six-protein shelterin complex — TRF1/TRF2 on duplex DNA, TPP1–POT1 on the single-stranded overhang, bridged by TIN2 and capped by RAP1 — stabilises this structure and hides the chromosome end from the DNA damage machinery.

Why the T-loop matters: when telomeres shorten critically, the T-loop and shelterin complex can no longer form. The exposed chromosome end is then read by the cell as a double-strand break, triggering a persistent, p53-dependent DNA damage response that drives the cell into senescence.

12.3 Telomerase and Alternative Lengthening of Telomeres (ALT)

  1. Telomerase: a specialized ribonucleoprotein complex consisting of a catalytic reverse transcriptase subunit (TERT) and an intrinsic RNA template (TERC). It uses its RNA template to extend the 3′-ends of chromosomes, preventing shortening. Absent in most normal somatic cells, telomerase is active in germ cells, stem cells, and approximately 90% of human cancers.
  2. Alternative Lengthening of Telomeres (ALT): the remaining 10% of cancers use ALT, a homologous recombination-mediated DNA replication pathway that maintains telomere length in a telomerase-independent manner.
Section 13

13. The Mechanics of Mitosis (M-Phase)

Mitosis is the process of nuclear division that partitions newly replicated chromosomes equally into two daughter cells. It is divided into five morphologically distinct stages, followed by cytokinesis.

1. Prophase Chromatin condenses; centrosomes separate 2. Prometaphase Nuclear envelope breaks down; spindle binds kinetochores 3. Metaphase Chromosomes align on the metaphase plate 4. Anaphase Sister chromatids pulled to opposite poles 5. Telophase Nuclear envelopes reform; chromosomes decondense 6. Cytokinesis Actomyosin ring constricts (cleavage) or cell plate forms

Figure 13.1: The stages of M-phase. Prophase through metaphase progressively organise the chromosomes and spindle; anaphase and telophase execute segregation and nuclear reformation; cytokinesis then physically divides the cytoplasm.

13.1 The Spindle Apparatus and Motor Forces

The mitotic spindle is a bipolar, microtubule-based machine assembled by centrosomes (animal cells) or dispersed microtubule-organising centres (plant cells), containing three functional classes of microtubules: kinetochore microtubules (attach to kinetochores, guiding chromosome movement), polar/interpolar microtubules (overlap at the spindle equator, maintaining spindle integrity), and astral microtubules (radiate to the cell cortex, anchoring and orienting the spindle).

Astral MT — Dynein Cortex-anchored; pulls pole toward cortex Polar MT — Kinesin-5 Slides MTs; pushes poles apart (opposed by Kinesin-14) Pole Pole Kinetochore MT — Kinesin-13 (MCAK) depolymerises the fibre, shortening it Chromosome Arms — Kinesin-4/10 Push arms toward the equator (polar ejection force)

Figure 13.2: Spindle motor proteins. Dynein at the cortex and Kinesin-5 at the polar-MT overlap set spindle length and pole separation (opposed respectively by nothing and by Kinesin-14); Kinesin-13/MCAK shortens kinetochore fibres to move chromosomes poleward (Anaphase A); Kinesin-4/10 push chromosome arms toward the equator, generating the polar ejection force that assists congression.

13.2 Chromosome Congression and Anaphase A vs. B

  1. Search-and-capture: Centrosomes nucleate highly dynamic microtubules that search the nuclear space. A microtubule captures a kinetochore on one side, and this unattached chromosome is initially pushed toward the equator by chromokinesins. The sister kinetochore is eventually captured by a microtubule from the opposite pole, establishing correct bipolar attachment, and the chromosome oscillates before aligning at the metaphase plate.
  2. Anaphase A (chromosome movement): sister chromatids move toward their respective poles, driven by depolymerisation of kinetochore microtubule plus-ends via Kinesin-13.
  3. Anaphase B (pole separation): the spindle poles themselves separate, driven by Kinesin-5 sliding overlapping polar microtubules, combined with cortical dynein pulling on astral microtubules.
Section 14

14. Molecular Mechanisms of Cytokinesis

Cytokinesis is the physical division of the cytoplasm to partition the two daughter nuclei. The mechanisms differ fundamentally between animal and plant cells.

14.1 Animal Cells: The Actomyosin Contractile Ring

  1. Central Spindle Assembly: Following chromosome segregation, overlapping polar microtubules form the central spindle, regulated by the chromosomal passenger complex (containing Aurora B kinase) and the centralspindlin complex (CSC).
  2. RhoA Activation: Active centralspindlin recruits the Rho-GEF Ect2 to the cell equator. Ect2 activates the small GTPase RhoA by promoting GDP-to-GTP exchange.
  3. Contractile Ring Assembly: Active RhoA-GTP initiates two parallel pathways — RhoA-GTP activates diaphanous (a formin), which nucleates and polymerises unbranched actin filaments; and RhoA-GTP activates ROCK (Rho-Associated Kinase), which phosphorylates the regulatory light chain of Myosin II, promoting its assembly into active bipolar filaments.
  4. Constriction and Abscission: The sliding of Myosin II along actin filaments constricts the cell membrane, forming a cleavage furrow. This leaves a thin intercellular bridge containing the midbody; final membrane scission (abscission) is executed by the ESCRT complex.
Central Spindle Assembly Centralspindlin Complex Ect2 (Rho-GEF) Active RhoA-GTP Diaphanous (Formin) ROCK Nucleates Actin Filaments Phosphorylates Myosin II Regulatory Light Chain CONTRACTILE RING

Figure 14.1: RhoA-driven contractile ring assembly. Centralspindlin activates the Rho-GEF Ect2, switching RhoA into its GTP-bound active state. Active RhoA then drives two parallel arms simultaneously — actin nucleation via diaphanous, and myosin activation via ROCK — that converge on the same contractile ring.

14.2 Plant Cells: The Phragmoplast and Cell Plate

Because plant cells are encased in a rigid cell wall, cytokinesis cannot occur via a cleavage furrow. Instead, they construct a new cell wall from the inside out.

G2 Phase Preprophase band (PPB) marks the division planeAnaphase / Telophase Cell plate forms and grows centrifugally (phragmoplast-guided)

Figure 14.2: Plant cytokinesis. The preprophase band marks the future division plane before mitosis even begins. After anaphase, the phragmoplast — a double-ringed microtubule array between the daughter nuclei — guides Golgi-derived vesicles carrying wall precursors to the equator; these fuse into a cell plate that grows centrifugally until it fuses with the parental wall.

Section 15

15. Meiosis: The Molecular Mechanics of Reductional Division

Meiosis is a specialized form of cell division that reduces the chromosome number by half, producing four haploid gametes. It consists of one round of DNA replication followed by two successive rounds of chromosome segregation: Meiosis I (reductional — separates homologous chromosomes, reducing ploidy from 2n to n) and Meiosis II (equational — separates sister chromatids, maintaining ploidy at n).

15.1 The Sub-stages of Prophase I

Prophase I is exceptionally prolonged and is divided into five distinct stages:

1. Leptotene Chromatin condenses to thin threads; telomeres form a bouquet 2. Zygotene Homologous synapsis begins; synaptonemal complex assembles 3. Pachytene Synapsis complete; crossing over at recombination nodules 4. Diplotene SC dissolves; homologs repel but stay linked at chiasmata 5. Diakinesis Chromosomes condense fully; nuclear envelope breaks down (NEBD)

Figure 15.1: The five sub-stages of Prophase I. Homolog pairing (synapsis) is assembled during zygotene and completed by pachytene, when crossing over occurs at recombination nodules initiated by the Spo11 endonuclease. The synaptonemal complex then dissolves in diplotene, leaving homologs linked only at chiasmata, before full condensation and nuclear envelope breakdown in diakinesis.

15.2 Structural Biology of the Synaptonemal Complex

The synaptonemal complex is a tripartite, proteinaceous ladder-like structure that stabilises homologous pairing: two outer lateral elements (SYCP2, SYCP3) bind directly to the chromatin of each homologous chromosome; a central element (SYCP1, SYCP2, SYCP3) runs along the axis of pairing; and transverse filaments, composed of SYCP1 homodimers, form the rungs that bridge the lateral and central elements.

Lateral Element (SYCP2, SYCP3) ≡ Chromatin Transverse Filaments (SYCP1) Central Element (SYCP1, 2, 3) Transverse Filaments (SYCP1) Lateral Element (SYCP2, SYCP3) ≡ Chromatin

Figure 15.2: The synaptonemal complex. A protein ladder that zips homologous chromosomes together along their length, providing the structural scaffold within which crossing over is executed at pachytene.

15.3 Meiosis I vs. Meiosis II Segregation Kinetics

  1. Meiosis I (Reductional): homologous chromosomes align and are pulled to opposite poles; sister chromatids remain linked at their centromere because cohesin along the chromosome arms is cleaved to release homologous pairing, while centromeric cohesin (containing Rec8) is protected from cleavage by the phosphatase shugoshin, which prevents separase action at the centromere.
  2. Meiosis II (Equational): following a brief interkinesis without DNA replication, shugoshin is no longer present at the centromere, allowing separase to cleave centromeric Rec8 and separate the sister chromatids — mechanically identical to mitotic anaphase.
Section 16

16. Nondisjunction, Aneuploidy, and Evolutionary Types of Meiosis

Errors in chromosome segregation during meiosis result in gametes with abnormal chromosome numbers, a condition termed aneuploidy. Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate during division.

Meiosis I Nondisjunction Homologous chromosomes fail to separate n+1 n+1 n−1 n−1 100% gametes abnormalMeiosis II Nondisjunction Sister chromatids fail to separate n n n+1 n−1 50% gametes abnormal

Figure 16.1: Meiosis I vs. Meiosis II nondisjunction. When homologs fail to separate in MI, every downstream gamete is abnormal because the error is present before MII even begins. When sister chromatids fail to separate in MII, only the two gametes derived from that one abnormal MII division are affected — the other MII division (from the other MI product) proceeds normally.

Common exam trap: MI nondisjunction gives 100% abnormal gametes (all four), while MII nondisjunction gives only 50% abnormal gametes (two of four) — a frequently tested quantitative distinction.

16.1 Evolutionary Classification of Meiotic Cycles

The timing of meiosis relative to fertilisation varies across eukaryotic taxa, defining three distinct lifecycle types:

Gametic Meiosis Diploid (2n) Multicellular Meiosis Gametes (n) Fertilisation Zygote (2n) (grows into new diploid organism)Zygotic Meiosis Haploid (n) Multicellular (mitosis) Gametes (n) Fertilisation Zygote (2n) (Meiosis restores the haploid state)Sporic Meiosis Sporophyte (2n) Multicellular Meiosis Spores (n) (mitosis) Gametophyte (n) Multicellular (mitosis) Gametes (n) (Fertilisation restores the 2n sporophyte)

Figure 16.2: Three evolutionary meiosis strategies. Gametic meiosis (animals) keeps the multicellular body diploid, with meiosis restricted to gamete formation. Zygotic meiosis (most fungi, some algae) keeps the body haploid, with meiosis occurring immediately after fertilisation. Sporic meiosis (plants) alternates between a diploid sporophyte and a haploid gametophyte generation.

Section 17

17. Stem Cell Potency, Niches, and Yamanaka Reprogramming

Stem cells are unspecialised progenitor cells characterised by two fundamental properties: self-renewal (the ability to divide indefinitely while maintaining an undifferentiated state) and potency (the capacity to differentiate into specialized cell types).

17.1 Potency Classifications

Totipotent All embryonic + extraembryonic lineages e.g. Zygote, early morula Pluripotent All 3 germ layers (ecto/endo/mesoderm) e.g. Embryonic stem cells (ESCs) Multipotent Restricted to lineages within a tissue e.g. Hematopoietic, mesenchymal SCs Oligopotent A few closely related cell types e.g. Lymphoid progenitor cells Unipotent One cell type; self-renewing e.g. Spermatogonial stem cells

Figure 17.1: The potency hierarchy. Developmental potential narrows progressively from totipotent (can form an entire organism, including extraembryonic tissue) down to unipotent (a single, self-renewing lineage) — each step is a one-way restriction under normal physiology.

17.2 The Stem Cell Niche

Adult stem cells reside within specialized, anatomically defined microenvironments termed stem cell niches. The niche provides physical support, cell-to-cell contacts, and extracellular signals (Wnt, Notch, BMP) that balance self-renewal and differentiation. During division, a stem cell can divide symmetrically (producing two stem cells or two differentiated cells) or asymmetrically, where one daughter remains in the niche to preserve the stem cell pool while the other exits and differentiates. If a stem cell exits the niche, it loses these supportive signals and initiates differentiation.

17.3 Yamanaka Reprogramming (iPSCs)

In 2006, Kazutoshi Takahashi and Shinya Yamanaka demonstrated that differentiated mammalian somatic cells can be reprogrammed back into pluripotent stem cells. By using retroviral vectors to force expression of four transcription factors — the Yamanaka factors (OSKM) — in fibroblasts, they generated Induced Pluripotent Stem Cells (iPSCs).

Somatic Cell (Differentiated Fibroblast) Yamanaka Factors (OSKM) • Oct3/4 — pluripotency TF • Sox2 — pluripotency TF • c-Myc — chromatin remodeller • Klf4 — suppresses apoptosis Induced Pluripotent Stem Cell (ESC-like: Pluripotent & Self-renewing)

Figure 17.2: Yamanaka reprogramming. Forced expression of just four transcription factors is sufficient to erase a somatic cell's differentiated identity and reset it to a pluripotent, ESC-like state — direct experimental proof that differentiation is not an irreversible process.

Why c-Myc and Klf4 matter: Oct3/4 and Sox2 alone activate the core pluripotency network, but c-Myc's chromatin-opening activity is needed for the other factors to reach their target genes efficiently, and Klf4's suppression of p53-driven apoptosis is needed to keep cells alive through the oncogenic stress that c-Myc itself creates — the four factors work as a balanced, interdependent set rather than four independent switches.

In this lesson

Scroll to Top